The Plight of Academic 'Marginals'

Major universities employ many Ph.D.s in academically marginal positions. Neither postdocs nor full-fledged faculty, these scientists populate an academic never-never land made possible by the availability of research support and made miserable by the difficulty of obtaining such support and by their ambiguous status in the institution. These scientists have such titles as "assistant research anatomist" or search associate," although some carry the usual academic titles along with the unusual re

Written byEdward Hackett
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The scientists I have interviewed in this status are quite capable by most measures. They have doctorates from very good departments, research support from NIH or NSF, several publications and good citation records. For example, the first-authored publications of one young marginal scientist in my sample had been cited more than 60 times according to the 1985 Science Citation Index. Thus, although the positions are marginal to academia (and, perhaps, also to the social organization of science), the researchers themselves are not marginal to the intellectual enterprise of science.

Yet the conditions of employment in such positions are often undesirable. The salaries are usually lower than academic salaries and the positions may not provide full-time pay, even if they demand full-time work. There is also little job security: employment usually ends when a project ends. Moreover, marginals have limited academic rights, such as claims on laboratory and office space or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies